DC District Court Sides With FDA In Alphapharma's Celexa Patent Challenge
A U.S. District Judge has dismissed a patent challenge to Forest Laboratories' antidepressant drug Celexa by Australian drugmaker Alphapharm Pty. Ltd., upholding a decision by the U.S. Food and Drug Administration...To view the full article, register now.
Already a subscriber? Click here to view full article